Literature DB >> 26232171

Platelets induce apoptosis via membrane-bound FasL.

Rebecca I Schleicher1, Frank Reichenbach2, Peter Kraft3, Anil Kumar4, Mario Lescan5, Franziska Todt6, Kerstin Göbel7, Ingo Hilgendorf8, Tobias Geisler9, Axel Bauer9, Marcus Olbrich1, Martin Schaller10, Sebastian Wesselborg11, Lorraine O'Reilly12, Sven G Meuth7, Klaus Schulze-Osthoff13, Meinrad Gawaz9, Xuri Li14, Christoph Kleinschnitz3, Frank Edlich15, Harald F Langer1.   

Abstract

After tissue injury, both wound sealing and apoptosis contribute to restoration of tissue integrity and functionality. Although the role of platelets (PLTs) for wound closure and induction of regenerative processes is well established, the knowledge about their contribution to apoptosis is incomplete. Here, we show that PLTs present the death receptor Fas ligand (FasL) on their surface after activation. Activated PLTs as well as the isolated membrane fraction of activated PLTs but not of resting PLTs induced apoptosis in a dose-dependent manner in primary murine neuronal cells, human neuroblastoma cells, and mouse embryonic fibroblasts. Membrane protein from PLTs lacking membrane-bound FasL (FasL(△m/△m)) failed to induce apoptosis. Bax/Bak-mediated mitochondrial apoptosis signaling in target cells was not required for PLT-induced cell death, but increased the apoptotic response to PLT-induced Fas signaling. In vivo, PLT depletion significantly reduced apoptosis in a stroke model and an inflammation-independent model of N-methyl-d-aspartic acid-induced retinal apoptosis. Furthermore, experiments using PLT-specific PF4Cre(+) FasL(fl/fl) mice demonstrated a role of PLT-derived FasL for tissue apoptosis. Because apoptosis secondary to injury prevents inflammation, our findings describe a novel mechanism on how PLTs contribute to tissue homeostasis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26232171      PMCID: PMC4573871          DOI: 10.1182/blood-2013-12-544445

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  67 in total

Review 1.  Fas ligand-induced apoptosis.

Authors:  S Nagata
Journal:  Annu Rev Genet       Date:  1999       Impact factor: 16.830

2.  Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L).

Authors:  D C Huang; M Hahne; M Schroeter; K Frei; A Fontana; A Villunger; K Newton; J Tschopp; A Strasser
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

3.  Activated human platelets express Fas-L and induce apoptosis in Fas-positive tumor cells.

Authors:  R Ahmad; J Menezes; L Knafo; A Ahmad
Journal:  J Leukoc Biol       Date:  2001-01       Impact factor: 4.962

4.  Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations.

Authors:  R M Siegel; J K Frederiksen; D A Zacharias; F K Chan; M Johnson; D Lynch; R Y Tsien; M J Lenardo
Journal:  Science       Date:  2000-06-30       Impact factor: 47.728

Review 5.  Mechanisms, challenges and opportunities in stroke.

Authors:  Eng H Lo; Turgay Dalkara; Michael A Moskowitz
Journal:  Nat Rev Neurosci       Date:  2003-05       Impact factor: 34.870

6.  FTY720 ameliorates acute ischemic stroke in mice by reducing thrombo-inflammation but not by direct neuroprotection.

Authors:  Peter Kraft; Eva Göb; Michael K Schuhmann; Kerstin Göbel; Carsten Deppermann; Ina Thielmann; Alexander M Herrmann; Kristina Lorenz; Marc Brede; Guido Stoll; Sven G Meuth; Bernhard Nieswandt; Waltraud Pfeilschifter; Christoph Kleinschnitz
Journal:  Stroke       Date:  2013-09-12       Impact factor: 7.914

7.  Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome.

Authors:  J Ware; S Russell; Z M Ruggeri
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

8.  The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues.

Authors:  T Lindsten; A J Ross; A King; W X Zong; J C Rathmell; H A Shiels; E Ulrich; K G Waymire; P Mahar; K Frauwirth; Y Chen; M Wei; V M Eng; D M Adelman; M C Simon; A Ma; J A Golden; G Evan; S J Korsmeyer; G R MacGregor; C B Thompson
Journal:  Mol Cell       Date:  2000-12       Impact factor: 17.970

9.  The phosphodiesterase-4 inhibitor rolipram protects from ischemic stroke in mice by reducing blood-brain-barrier damage, inflammation and thrombosis.

Authors:  Peter Kraft; Tobias Schwarz; Eva Göb; Nadine Heydenreich; Marc Brede; Sven G Meuth; Christoph Kleinschnitz
Journal:  Exp Neurol       Date:  2013-04-06       Impact factor: 5.330

10.  Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival.

Authors:  A M Hohlbaum; S Moe; A Marshak-Rothstein
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

View more
  27 in total

1.  Platelet-RBC interaction mediated by FasL/FasR induces procoagulant activity important for thrombosis.

Authors:  Christoph Klatt; Irena Krüger; Saskia Zey; Kim-Jürgen Krott; Martina Spelleken; Nina Sarah Gowert; Alexander Oberhuber; Lena Pfaff; Wiebke Lückstädt; Kerstin Jurk; Martin Schaller; Hadi Al-Hasani; Jürgen Schrader; Steffen Massberg; Konstantin Stark; Hubert Schelzig; Malte Kelm; Margitta Elvers
Journal:  J Clin Invest       Date:  2018-08-13       Impact factor: 14.808

Review 2.  The Platelet Lifeline to Cancer: Challenges and Opportunities.

Authors:  Monika Haemmerle; Rebecca L Stone; David G Menter; Vahid Afshar-Kharghan; Anil K Sood
Journal:  Cancer Cell       Date:  2018-04-12       Impact factor: 31.743

3.  The red blood cell death receptor and thrombosis.

Authors:  Nigel Mackman
Journal:  J Clin Invest       Date:  2018-08-13       Impact factor: 14.808

4.  Association of FAS A-670G Polymorphism and Risk of Uterine Leiomyoma in a Southeast Iranian Population.

Authors:  Abbas Mohammadpour-Gharehbagh; Saeedeh Salimi; Farshid Keshavarzi; Sepideh Zakerian; Mojtaba Sajadian; Mojgan Mokhtari
Journal:  Rep Biochem Mol Biol       Date:  2016-10

5.  Functional Relevance of the Anaphylatoxin Receptor C3aR for Platelet Function and Arterial Thrombus Formation Marks an Intersection Point Between Innate Immunity and Thrombosis.

Authors:  Reinhard J Sauter; Manuela Sauter; Edimara S Reis; Frederic N Emschermann; Henry Nording; Sonja Ebenhöch; Peter Kraft; Patrick Münzer; Maximilian Mauler; Johannes Rheinlaender; Johannes Madlung; Frank Edlich; Tilman E Schäffer; Sven G Meuth; Daniel Duerschmied; Tobias Geisler; Oliver Borst; Meinrad Gawaz; Christoph Kleinschnitz; John D Lambris; Harald F Langer
Journal:  Circulation       Date:  2018-10-16       Impact factor: 29.690

Review 6.  The contribution of platelets to intravascular arrest, extravasation, and outgrowth of disseminated tumor cells.

Authors:  Amelia Foss; Leonel Muñoz-Sagredo; Jonathan Sleeman; Wilko Thiele
Journal:  Clin Exp Metastasis       Date:  2019-11-22       Impact factor: 5.150

7.  Inflammatory markers in chronic kidney disease and end stage renal disease patients.

Authors:  Mahmoud M Zakaria; Safaa A Derbala; Ayman E Salem; Amgad E El-Agroudy; Fatma M El-Tantawy
Journal:  Mol Biol Rep       Date:  2021-09-01       Impact factor: 2.316

Review 8.  Platelets in Neurodegenerative Conditions-Friend or Foe?

Authors:  Odette Leiter; Tara L Walker
Journal:  Front Immunol       Date:  2020-05-05       Impact factor: 7.561

Review 9.  The Inflammatory Role of Platelets: Translational Insights from Experimental Studies of Autoimmune Disorders.

Authors:  Susann Pankratz; Stefan Bittner; Beate E Kehrel; Harald F Langer; Christoph Kleinschnitz; Sven G Meuth; Kerstin Göbel
Journal:  Int J Mol Sci       Date:  2016-10-14       Impact factor: 5.923

10.  Phospholipase D1 regulation of TNF-alpha protects against responses to LPS.

Authors:  Marc-Andre Urbahn; Sonja Charlotte Kaup; Friedrich Reusswig; Irena Krüger; Martina Spelleken; Kerstin Jurk; Meike Klier; Philipp A Lang; Margitta Elvers
Journal:  Sci Rep       Date:  2018-07-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.